Intellia is developing treatments with CRISPR/Cas9 that will focus on genome editing in somatic cells in the liver. In preclinical (non-human) studies, we observed that the target gene in the liver was edited, resulting in reduced production of the target protein. We also observed that circulating levels of protein produced by the target gene were … Continue reading Can CRISPR/Cas9 edit genes all throughout my body?